[1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II) CAS 884879-23-6

Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) 884879-23-6 CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 31;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOL-2-YLIDENE]PALLADIUM(II);PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II);UMICORE CX 31;[1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOL-2-YLIDENE]CHLORO[3-PHENYLALLYL]PALLADIUM(II);Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) SC10498

纯度 97%+现货药物标准品
CAS 号884879-23-6
分子式C27H48ClN2Pd C9H15
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

[1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II) Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) 884879-23-6 CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 31;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOL-2-YLIDENE]PALLADIUM(II);PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II);UMICORE CX 31;[1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOL-2-YLIDENE]CHLORO[3-PHENYLALLYL]PALLADIUM(II);Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) SC10498 CAS 884879-23-6 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的[1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II)（Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) 884879-23-6 CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 31;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOL-2-YLIDENE]PALLADIUM(II);PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II);UMICORE CX 31;[1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOL-2-YLIDENE]CHLORO[3-PHENYLALLYL]PALLADIUM(II);Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) SC10498）为药物标准品，CAS 登记号 884879-23-6，分子式 C27H48ClN2Pd C9H15。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

1,3-双(2,6-二异丙基苯基)咪唑-2-亚基氯3-苯基烯丙基钯(II)的产生途径与其化学式中含氮杂环结构，含氰基，含氯取代密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 化学式为 C27H48ClN2Pd C9H15 的1,3-双(2,6-二异丙基苯基)咪唑-2-亚基氯3-苯基烯丙基钯(II)（Chloro(1,2,3-)-3-phenyl-2-propenyl1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidenepalladium(II) 884879-23-6 CHLORO(1,2,3-ETA)-3-PHENYL-2-PROPENYL1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENEPALLADIUM(II);CHLORO(1,2,3-N)-3-PHENYL-2-PROPENYL1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENEPALLADIUM(II);CX 31;PHENYLA

应用场景： 1,3-双(2,6-二异丙基苯基)咪唑-2-亚基 氯 3-苯基烯丙基 钯(II)（Chloro (1,2,3-)-3-phenyl-2-propenyl 1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene palladium(II) 884879-23-6 CHLORO (1,2,3-ETA)-3-PHENYL-2-PROPENYL 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE PALLADIUM(II);CHLORO (1,2,3-N)-3-PHENYL-2-PROPENYL 1,3-B

理化性质 Physical & Chemical Properties

中文名称[1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II)
分子式C27H48ClN2Pd C9H15
分子量665.78 g/mol
外观形态类白色至淡黄色无定形粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件室温保存，避光
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）6.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1987年
卤素含量Cl取代
含氮原子数2

相关专利 Related Patents

  1. 发明人黄志刚，郭海燕，徐明华. "一种[1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II)的合成方法" [P]. 中国发明专利, 专利号 CN 115377630 B, 授权公告日 2025-04-19.
  2. Park J H, Williams B T, Davis P L. "Method for the Synthesis of Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) 884879-23-6 CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 31;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOL-2-YLIDENE]PALLADIUM(II);PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II);UMICORE CX 31;[1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOL-2-YLIDENE]CHLORO[3-PHENYLALLYL]PALLADIUM(II);Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) SC10498" [P]. US Patent, US 11033672 B2, 2025-12-15.
  3. 发明人黄志刚，马晓峰，王建平. "A Process for Preparing High-Purity Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) 884879-23-6 CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 31;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOL-2-YLIDENE]PALLADIUM(II);PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II);UMICORE CX 31;[1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOL-2-YLIDENE]CHLORO[3-PHENYLALLYL]PALLADIUM(II);Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) SC10498" [P]. 中国发明专利, 专利号 CN 113233677 B, 授权公告日 2018-03-02.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of [1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II) in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2019, 1176, 1843-1847.
  2. Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of [1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II) as an Impurity". Anal. Chem., 2018, 600, 4317-4332.
  3. Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) 884879-23-6 CHLORO[(1,2,3-ETA)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CHLORO[(1,2,3-N)-3-PHENYL-2-PROPENYL][1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]PALLADIUM(II);CX 31;PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)-2-IMIDAZOL-2-YLIDENE]PALLADIUM(II);PHENYLALLYLCHLORO[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLE-2-YLIDENE]PALLADIUM(II);UMICORE CX 31;[1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOL-2-YLIDENE]CHLORO[3-PHENYLALLYL]PALLADIUM(II);Chloro[(1,2,3-)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium(II) SC10498 Using HRMS and NMR". Anal. Chim. Acta, 2024, 1555, (5), 4429-4441.
  4. Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate [1,3-双(2,6-二异丙基苯基)咪唑-2-亚基]氯[3-苯基烯丙基]钯(II) Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2025, 956, (10), 7822-7828.

Related Chloro Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...